365 results on '"Yankelevitz, David"'
Search Results
2. AI-enabled left atrial volumetry in coronary artery calcium scans (AI-CACTM) predicts atrial fibrillation as early as one year, improves CHARGE-AF, and outperforms NT-proBNP: The multi-ethnic study of atherosclerosis
3. AI-enabled cardiac chambers volumetry in coronary artery calcium scans (AI-CACTM) predicts heart failure and outperforms NT-proBNP: The multi-ethnic study of Atherosclerosis
4. Timeliness of surgery for early-stage lung cancer: Patient factors and predictors
5. AI-enabled Left Atrial Volumetry in Cardiac CT Scans Improves CHARGE-AF and Outperforms NT-ProBNP for Prediction of Atrial Fibrillation in Asymptomatic Individuals: Multi-Ethnic Study of Atherosclerosis
6. Coronary Artery Calcium Scans Powered by Artificial Intelligence Predicts Atrial Fibrillation Comparably to Cardiac Magnetic Resonance Imaging: The Multi-Ethnic Study of Atherosclerosis (MESA)
7. AI-powered Coronary Artery Calcium Scans (AI-CAC) Enables Prediction of Heart Failure and Outperforms NT-proBNP: The Multi-Ethnic Study of Atherosclerosis
8. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations
9. CT Predictors of Visceral Pleural Invasion in Patients with Non–Small Cell Lung Cancers 30 mm or Smaller
10. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery
11. Abstract 19109: AI-Enabled Automated Cardiac Chambers Volumetry in ECG-Gated Coronary Calcium Scans vs. Non-Gated Lung Cancer Screening Scans
12. Considerations for Incorporating Family History Into Low-dose Computed Tomography Screening Recommendations
13. The Association of Organizational Readiness With Lung Cancer Screening Utilization
14. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations
15. Calibration phantom-based prediction of CT lung nodule volume measurement performance
16. Rural barriers and facilitators of lung cancer screening program implementation in the veterans health administration: a qualitative study
17. The IASLC Early Lung Imaging Confederation (ELIC) Open-Source Deep Learning and Quantitative Measurement Initiative
18. Abstract CT199: Rescuing response to ICI by blocking the type-2 immune axis in patients with NSCLC progressing on immunotherapy: A phase 1b/2 trial of dupilumab administered with checkpoint blockade
19. Emphysema Detection in the Course of Lung Cancer Screening: Optimizing a Rare Opportunity to Impact Population Health
20. Environmental exposures are important risk factors for advanced liver fibrosis in African American adults
21. PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients
22. Management of Small Histologic and Cytologic Specimens in the Molecular Era
23. Contributors
24. A pilot trial evaluating the rapid sequencing of approved therapies in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC).
25. A narrative review of lung cancer screening: risks of lung cancer screening
26. Evaluation of emphysema on thoracic low-dose CTs through attention-based multiple instance deep learning
27. Using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) to study adaptations in lung cancer screening delivery in the Veterans Health Administration: a cohort study
28. Opportunistic AI-enabled automated bone mineral density measurements in lung cancer screening and coronary calcium scoring CT scans are equivalent
29. Impact of Duration of Diagnostic Workup on Prognosis for Early Lung Cancer
30. New or enlarging hiatal hernias after thoracic surgery for early lung cancer
31. Environmental exposures are important risk factors for advanced liver fibrosis in African American adults: NHANES 1999-2018
32. The radiologist’s role in pathologic diagnosis of small lung nodules: radiographic methods of tissue acquisition
33. Review of the future of lung cancer screening
34. 629 Neoadjuvant nivolumab combined with CCR2/5 inhibitor or anti-IL-8 antibody in non-small cell lung cancer and hepatocellular carcinoma
35. Comparison of lung cancer aggressiveness in patients who never smoked compared to those who smoked
36. Using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) to study lung cancer screening adaptations in the Veterans Health Administration
37. Bronchiectasis in Low-Dose CT Screening for Lung Cancer
38. Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
39. Abstract CT205: A phase I/Ib trial of intratumoral Poly-ICLC in resectable malignant pleural mesothelioma
40. A phase 1b/2 trial of dupilumab given in conjunction with PD-(L)1 blockade in the treatment of relapsed/refractory metastatic NSCLC.
41. Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer
42. Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
43. Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation
44. Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration
45. Opportunistic CT screening of osteoporosis on thoracic and lumbar spine: a meta-analysis
46. Pre-surgical assessment of mediastinal lymph node metastases in patients having ≥ 30 mm non-small-cell lung cancers
47. Effects of Smoking, Obesity, and Pulmonary Function on Home Oxygen Use after Curative Lung Cancer Surgery
48. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD
49. Early prediction of severity in coronavirus disease (COVID-19) using quantitative CT imaging
50. QIBA guidance: Computed tomography imaging for COVID-19 quantitative imaging applications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.